Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When genetic tenofovir alafenamide be available in us?
How many years does kadcyla's market exclusivity last?
Patent expiry trametinib?
How long have hydroxyzine pamoate been on the market?
Is januvia still on the market?

Keytruda's initial target which cancer was it?

See the DrugPatentWatch profile for Keytruda

Keytruda (pembrolizumab) targets PD-1 (programmed cell death protein 1) on T cells.

Its first FDA-approved cancer indication (2014) was advanced/metastatic melanoma (unresectable), i.e., the initial cancer it was approved to treat.



Other Questions About Keytruda :

Keytruda patent expiry impact? What are the most frequent adverse reactions to keytruda? Keytruda history? What are keytruda s rare but serious side effects? Keytruda brand name or generic name? When does keytruda s patent expire? Patent apprication number keytruda?